- Home
- GOVX vs CLRO Comparison
GOVX vs CLRO Comparison
Compare GOVX & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOVX
- CLRO
- Stock Information
- Founded
- GOVX 2001
- CLRO 1983
- Country
- GOVX United States
- CLRO United States
- Employees
- GOVX N/A
- CLRO N/A
- Industry
- GOVX Biotechnology: Pharmaceutical Preparations
- CLRO Radio And Television Broadcasting And Communications Equipment
- Sector
- GOVX Health Care
- CLRO Technology
- Exchange
- GOVX Nasdaq
- CLRO Nasdaq
- Market Cap
- GOVX 7.6M
- CLRO 7.5M
- IPO Year
- GOVX N/A
- CLRO N/A
- Fundamental
- Price
- GOVX $0.68
- CLRO $5.05
- Analyst Decision
- GOVX Strong Buy
- CLRO
- Analyst Count
- GOVX 3
- CLRO 0
- Target Price
- GOVX $10.67
- CLRO N/A
- AVG Volume (30 Days)
- GOVX 690.2K
- CLRO 94.6K
- Earning Date
- GOVX 11-11-2025
- CLRO 11-14-2025
- Dividend Yield
- GOVX N/A
- CLRO N/A
- EPS Growth
- GOVX N/A
- CLRO N/A
- EPS
- GOVX N/A
- CLRO N/A
- Revenue
- GOVX $6,143,044.00
- CLRO $9,689,000.00
- Revenue This Year
- GOVX N/A
- CLRO N/A
- Revenue Next Year
- GOVX N/A
- CLRO N/A
- P/E Ratio
- GOVX N/A
- CLRO N/A
- Revenue Growth
- GOVX 1943.07
- CLRO N/A
- 52 Week Low
- GOVX $0.43
- CLRO $3.83
- 52 Week High
- GOVX $3.88
- CLRO $21.00
- Technical
- Relative Strength Index (RSI)
- GOVX 41.08
- CLRO 56.18
- Support Level
- GOVX $0.65
- CLRO $4.09
- Resistance Level
- GOVX $0.73
- CLRO $5.01
- Average True Range (ATR)
- GOVX 0.04
- CLRO 0.41
- MACD
- GOVX -0.00
- CLRO 0.18
- Stochastic Oscillator
- GOVX 21.28
- CLRO 82.50
About GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
About CLRO ClearOne Inc. (DE)
ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.